Calcium scores and matrix Gla protein levels: association with vitamin K status
- 17 March 2010
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 40 (4), 344-349
- https://doi.org/10.1111/j.1365-2362.2010.02275.x
Abstract
Vascular calcification in humans is associated with an increased cardiovascular risk. Carboxylated matrix Gla protein (cMGP) inhibits vascular calcification. Vitamin K is an essential cofactor for the activation of uncarboxylated matrix Gla protein (ucMGP). It has been suggested that patients on long-term treatment with vitamin K antagonists develop aortic valve calcifications because of lower levels of circulating MGP. We therefore hypothesized that arterial calcification and a low vitamin K status are associated with ucMGP. To that aim, we measured arterial calcium scores, the osteocalcin ratio (OCR), as a proxy for vitamin K status, and ucMGP. In 36 hypertensive patients, we determined the Agatston score with computer tomography scans of the abdominal aorta, carotid and coronary arteries. The total calcium score was calculated as the sum of the separate Z-scores. The total calcium Z-score was significantly correlated to age (r = 0.683, P < 0.001), smoking (r = 0.372, P = 0.026), total cholesterol (r = 0.353, P = 0.034), LDL cholesterol (r = 0.490, P = 0.003), triglycerides (r = 0.506, P = 0.002), fasting glucose (r = 0.454, P = 0.005), systolic blood pressure (r = 0.363, P = 0.029) and pulse pressure (r = 0.685, P < 0.001). In multivariate regression analyses, OCR and total calcium score were significantly associated with ucMGP. We found a positive association of total arterial calcium score and a high OCR (reflecting low vitamin K status) with ucMGP serum levels. This warrants further studies to explore the pathophysiological background of this phenomenon.Keywords
This publication has 37 references indexed in Scilit:
- Vitamin K supplementation and progression of coronary artery calcium in older men and womenThe American Journal of Clinical Nutrition, 2009
- Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysisVascular Health and Risk Management, 2009
- The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysisNephrology Dialysis Transplantation, 2008
- The Circulating Inactive Form of Matrix Gla Protein (ucMGP) as a Biomarker for Cardiovascular CalcificationJournal of Vascular Research, 2008
- Presence of Abdominal Aortic Calcification Is Significantly Associated With All-Cause and Cardiovascular Mortality in Maintenance Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2007
- Matrix Gla Protein Is Associated With Risk Factors for Atherosclerosis but not With Coronary Artery CalcificationArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Relation of Oral Anticoagulation to Cardiac Valvular and Coronary Calcium Assessed by Multislice Spiral Computed TomographyThe American Journal of Cardiology, 2005
- Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal DiseaseHypertension, 2001
- Matrix Gla Protein Is Regulated by a Mechanism Functionally Related to the Calcium-Sensing ReceptorBiochemical and Biophysical Research Communications, 2000
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976